Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:28 PM
Ignite Modification Date:
2025-12-24 @ 6:28 PM
NCT ID:
NCT01644968
Eligibility Criteria:
Inclusion Criteria:
* Patients with uncurable metastatic carcinoma, lymphoma, or sarcoma.
* ECOG performance status 0, 1, 2
* No active bleeding
* No clinical coagulopathy
* Anticipated lifespan greater than 12 weeks
Exclusion Criteria:
* Active residual toxicity from prior therapies
* Active Infection
* HIV positive
* Hepatitis B or C positive
* Pregnant or nursing women
* Requirement for oral steroids
* Brain metastases
* Presence or history of autoimmune disease
* Shellfish or tetanus allergy
* Splenomegaly
* Lymph nodes greater than 10 cm in maximal diameter
* Uncontrolled angina or class II or IV heart failure
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01644968
Study Brief:
Protocol Section:
NCT01644968